Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Shares Outstanding (Diluted Average) (2022 - 2025)

Indivior Pharmaceuticals (INDV) has 4 years of Shares Outstanding (Diluted Average) data on record, last reported at $128.0 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 3.76% year-over-year to $128.0 million; the TTM value through Dec 2025 reached $128.0 million, down 3.76%, while the annual FY2025 figure was $128.0 million, 3.76% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $128.0 million in Q4 2025 per INDV's latest filing, up from $127.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $139.0 million in Q4 2022 and bottomed at $125.0 million in Q1 2025.
  • Average Shares Outstanding (Diluted Average) over 4 years is $132.0 million, with a median of $133.5 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Diluted Average): decreased 1.44% in 2023, then decreased 8.76% in 2025.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $139.0 million in 2022, then fell by 1.44% to $137.0 million in 2023, then dropped by 2.92% to $133.0 million in 2024, then decreased by 3.76% to $128.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $128.0 million in Q4 2025, $127.0 million in Q3 2025, and $125.0 million in Q2 2025.